Findings from National Center for Immunization and Respiratory Diseases Provides New Data on Whooping Cough (Genome-based Prediction of Cross-protective, Hla-dr-presented Epitopes As Putative Vaccine Antigens for Multiple bordetella...).

A recent study conducted by the National Center for Immunization and Respiratory Diseases in Atlanta, Georgia, explores the potential for developing a more effective vaccine for whooping cough. The researchers aimed to identify vaccine antigens that could provide cross-protective immunity against multiple Bordetella pathogens. Through genomic analysis and immunoinformatics, they identified a list of peptides that may confer long-lasting T-cell immunity. This research has important implications for improving the efficacy of pertussis vaccines and protecting against other species that cause pertussis-like illness. [Extracted from the article]